Pretreatment with P2Y12 inhibitors in non-ST-Segment-elevation acute coronary syndrome: an outdated and harmful strategy

Circulation. 2014 Nov 18;130(21):1904-14; discussion 1914. doi: 10.1161/CIRCULATIONAHA.114.011320.

¹ From the Institut de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpêtriėre (ACTION Study Group, AP-HP, Université Paris 6), Paris, France (J.-P.C., J.S., and G.M.); and Department of Cardiology, Hospital La Fontonne, Antibes, France (A.B.-A.). jean-philippe.collet@psl.aphp.fr.
² From the Institut de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpêtriėre (ACTION Study Group, AP-HP, Université Paris 6), Paris, France (J.-P.C., J.S., and G.M.); and Department of Cardiology, Hospital La Fontonne, Antibes, France (A.B.-A.).

No abstract available

Publication types